Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice | ||
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Cátedra de Histología, Embriología y Genética II | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica | |
| dc.contributor.author | Gobbi, Paola | |
| dc.contributor.author | Lo Presti, Maria Silvina | |
| dc.contributor.author | Fernandez, Alicia Ruth | |
| dc.contributor.author | Enders, Julio Enrique | |
| dc.contributor.author | Fretes, Ricardo Emilio | |
| dc.contributor.author | Gea, Susana | |
| dc.contributor.author | Paglini, Patricia Adriana | |
| dc.contributor.author | Rivarola, Hector Walter | |
| dc.date.issued | 2007-07 | |
| dc.description.abstract | Abstract There is a real need for new and less toxic drugs for the treatment of Chagas disease, as nifurtimox and benznidazole are effective but toxic and provoke unpleasant side effects, especially in adult patients. Allopurinol, commonly used to treat the hiperuricemia, is also used by the Trypanosoma cruzi?s hypoxantine guanine fosforyltransferase as an alternative substrate incorporating it into the parasite?s ribonucleic acid, provoking the death of the parasite. However, the results of using allopurinol as chemotherapy for Chagas disease are not clear. For that, we investigated the evolution of the T. cruzi infection in mice treated with allopurinol (5, 10 or 15 mg/kg for 90 days) obtaining a reduction in the parasitaemia (p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.There is a real need for new and less toxic drugs for the treatment of Chagas disease, as nifurtimox and benznidazole are effective but toxic and provoke unpleasant side effects, especially in adult patients. Allopurinol, commonly used to treat the hiperuricemia, is also used by the Trypanosoma cruzi?s hypoxantine guanine fosforyltransferase as an alternative substrate incorporating it into the parasite?s ribonucleic acid, provoking the death of the parasite. However, the results of using allopurinol as chemotherapy for Chagas disease are not clear. For that, we investigated the evolution of the T. cruzi infection in mice treated with allopurinol (5, 10 or 15 mg/kg for 90 days) obtaining a reduction in the parasitaemia (p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.Trypanosoma cruzi?s hypoxantine guanine fosforyltransferase as an alternative substrate incorporating it into the parasite?s ribonucleic acid, provoking the death of the parasite. However, the results of using allopurinol as chemotherapy for Chagas disease are not clear. For that, we investigated the evolution of the T. cruzi infection in mice treated with allopurinol (5, 10 or 15 mg/kg for 90 days) obtaining a reduction in the parasitaemia (p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.?s ribonucleic acid, provoking the death of the parasite. However, the results of using allopurinol as chemotherapy for Chagas disease are not clear. For that, we investigated the evolution of the T. cruzi infection in mice treated with allopurinol (5, 10 or 15 mg/kg for 90 days) obtaining a reduction in the parasitaemia (p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.T. cruzi infection in mice treated with allopurinol (5, 10 or 15 mg/kg for 90 days) obtaining a reduction in the parasitaemia (p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.p< 0.05), no electrocardiographic alterations (p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.p<0.05) and a conserved myocardial and cardiac â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease.â-receptors? affinity values with the highest dose of the drug, compared to those of the uninfected mice. Cruzipain immunoglobulin G levels remained high in all the groups as well as the survival (70%, 90 days post-infection). Allopurinol prevented the acute phase evolving into the chronic cardiac disease. | es |
| dc.description.fil | Fil: Gobbi, Paola. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina | |
| dc.description.fil | Fil: Lo Presti, Maria Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina | |
| dc.description.fil | Fil: Fernandez, Alicia Ruth. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina | |
| dc.description.fil | Fil: Enders, Julio Enrique. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina | |
| dc.description.fil | Fil: Fretes, Ricardo Emilio. Universidad Nacional de Córdoba. Facultad de Medicina. Cátedra de Histología, Embriología y Genética II; Argentina | |
| dc.description.fil | Fil: Gea, Susana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina | |
| dc.description.fil | Fil: Paglini, Patricia Adriana. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina | |
| dc.description.fil | Fil: Rivarola, Hector Walter. Universidad Nacional de Córdoba. Facultad de Medicina. Departamento de Fisiología Humana y Física Biomedica. Cátedra de Física Biomedica; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Gobbi, Paola; Lo Presti, Maria Silvina; Fernandez, Alicia Ruth; Enders, Julio Enrique; Fretes, Ricardo Emilio; et al.; Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice; Springer; Parasitology Research; 101; 5; 7-2007; 1459-1462 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0932-0113 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/272776 | |
| dc.journal.number | 5 | es |
| dc.journal.pagination | 1459-1462 | es |
| dc.journal.pais | Alemania | es |
| dc.journal.title | Parasitology Research | es |
| dc.journal.volume | 101 | es |
| dc.language.iso | eng | es |
| dc.publisher | Springer | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s00436-007-0644-2 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/s00436-007-0644-2 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Trypanosoma cruzi’s | es |
| dc.subject | Chagas | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.32be1d98-65fe-4eb5-a667-6431e4ead880_B.pdf
- Tamaño:
- 178.97 KB
- Formato:
- Adobe Portable Document Format